This company listing is no longer active
Kee Song Bio-Technology Holdings Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 3/6
Kee Song Bio-Technology Holdings has a total shareholder equity of NT$757.8M and total debt of NT$1.0B, which brings its debt-to-equity ratio to 137.3%. Its total assets and total liabilities are NT$2.3B and NT$1.5B respectively. Kee Song Bio-Technology Holdings's EBIT is NT$155.8M making its interest coverage ratio 6.9. It has cash and short-term investments of NT$339.4M.
Anahtar bilgiler
137.3%
Borç/özkaynak oranı
NT$1.04b
Borç
| Faiz karşılama oranı | 6.9x |
| Nakit | NT$339.35m |
| Eşitlik | NT$757.79m |
| Toplam yükümlülükler | NT$1.51b |
| Toplam varlıklar | NT$2.27b |
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 1258's short term assets (NT$786.3M) exceed its short term liabilities (NT$571.3M).
Uzun Vadeli Yükümlülükler: 1258's short term assets (NT$786.3M) do not cover its long term liabilities (NT$937.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 1258's net debt to equity ratio (92.5%) is considered high.
Borcun Azaltılması: 1258's debt to equity ratio has increased from 129.9% to 137.3% over the past 5 years.
Borç Kapsamı: 1258's debt is well covered by operating cash flow (30.9%).
Faiz Kapsamı: 1258's interest payments on its debt are well covered by EBIT (6.9x coverage).